GovChime
Notice ID: d4a89274ddfa4531b5a29fc69d067298Combined Synopsis/Solicitation

Amendment 001_Synthesis Services for Custom Biomolecules for Detection of Mutation-Reactive T cells in Patients With Metastatic Cancers

Archived on September 30, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
6:00 PM UTC−04:00
Posted
August 7, 2024
Notice type
Combined Synopsis/Solicitation
NAICS
621511: Medical Laboratories
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NIH NCI
Place of performance
Bethesda, MD, 20892
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75N91024Q00094
Notice ID
d4a89274ddfa4531b5a29fc69d067298

Description

The purpose of Amendment 001 is to attach PDF "52.212-3(MAY2024)_FullText." Response date remains unchanged. ***Please read the attached documents*** The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Surgery Branch (SB) requires synthesis services for custom biomolecules for the detection of Mutation-Reactive T cells in patients with Metastatic Cancers. This is a Combined Synopsis/Solicitation for commercial items, prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, as supplemented with additional information included in this notice, and shall be processed in accordance with FAR 13.5 - Simplified Procedures for Certain Commercial Products and Commercial Services. This announcement constitutes the only solicitation that will be provided in relation to the stated need contained herein. This solicitation is issued as a Request for Quote (RFQ) and includes applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2024-05 (05/22/2024). One firm fixed priced award is anticipated to be made as a result of this solicitation. Please submit questions concerning this RFQ via email no later than 12:00PM EDT on Thursday, 08/08/2024. Quotes in response to this RFQ must be submitted via email no later than 6:00PM EDT on Monday, 08/12/2024.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N91024Q00094
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentAug 6, 2024

    Amendment 001_Synthesis Services for Custom Biomolecules for Detection of Mutation-Reactive T cells in Patients With Metastatic Cancers

    Notice d4a89274ddfa4531b5a29fc69d067298 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N91024Q00094

Archive Date

Sep 30, 2024

Office Address

Bethesda, MD, 20892